Kiniksa Pharmaceuticals International annual gross margin
2021
2022
2023
2024
2025
Kiniksa Pharmaceuticals International Gross Margin Growth & History (KNSA)
Kiniksa Pharmaceuticals International's gross margin was 88.54% for fiscal 2025.
View full Kiniksa Pharmaceuticals International company overviewKiniksa Pharmaceuticals International annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 88.54% | +2.93 pp |
| 2024 | 2024-12-31 | 85.61% | −2.03 pp |
| 2023 | 2023-12-31 | 87.64% | −1.96 pp |
| 2022 | 2022-12-31 | 89.60% | +13.21 pp |
| 2021 | 2021-12-31 | 76.39% | — |
Kiniksa Pharmaceuticals International quarterly gross margin
Q2.21
Q3.21
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 54.17% | −33.97 pp |
| Q1 2026 | 2026-03-31 | 90.29% | +3.26 pp |
| Q4 2025 | 2025-12-31 | 89.64% | +4.24 pp |
| Q3 2025 | 2025-09-30 | 88.80% | +6.72 pp |
| Q2 2025 | 2025-06-30 | 88.14% | −0.52 pp |
| Q1 2025 | 2025-03-31 | 87.03% | +0.28 pp |
| Q4 2024 | 2024-12-31 | 85.40% | −3.11 pp |
| Q3 2024 | 2024-09-30 | 82.08% | −4.37 pp |
| Q2 2024 | 2024-06-30 | 88.66% | −0.57 pp |
| Q1 2024 | 2024-03-31 | 86.75% | +1.30 pp |
| Q4 2023 | 2023-12-31 | 88.51% | — |
| Q3 2023 | 2023-09-30 | 86.45% | −6.56 pp |
| Q2 2023 | 2023-06-30 | 89.23% | +7.87 pp |
| Q1 2023 | 2023-03-31 | 85.45% | — |
| Q3 2022 | 2022-09-30 | 93.00% | +15.88 pp |
| Q2 2022 | 2022-06-30 | 81.35% | +13.36 pp |
| Q3 2021 | 2021-09-30 | 77.12% | — |
| Q2 2021 | 2021-06-30 | 67.99% | — |
Kiniksa Pharmaceuticals International gross margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Kiniksa Pharmaceuticals International's gross margin increased from 76.39% to 88.54%, a change of +12.15 percentage points. The latest reported quarter, Q2 2026, shows 54.17%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kiniksa Pharmaceuticals International source filings ↗